| Basics |
| Company: |
TransMedics Group, Inc. |
| IPO Date: |
April 29, 2019 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$2.41B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.34 | 2.86%
|
| Avg Daily Range (30 D): |
$2.45 | 3.66%
|
| Avg Daily Range (90 D): |
$2.24 | 2.96%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.47M |
| Avg Daily Volume (30 D): |
1.94M |
| Avg Daily Volume (90 D): |
1.8M |
| Trade Size |
| Avg Trade Size (Sh.): |
54 |
| Avg Trade Size (Sh.) (30 D): |
55 |
| Avg Trade Size (Sh.) (90 D): |
51 |
| Institutional Trades |
| Total Inst.Trades: |
2,382 |
| Avg Inst. Trade: |
$3.24M |
| Avg Inst. Trade (30 D): |
$2.44M |
| Avg Inst. Trade (90 D): |
$2.83M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.23M |
| Avg Closing Trade (30 D): |
$7.65M |
| Avg Closing Trade (90 D): |
$8.45M |
| Avg Closing Volume: |
61.73K |
|
|
|
|
| News |
Feb 22, 2025 @ 12:16 PM
TMDX CLASS ACTION DEADLINE: TransMedics Group, Inc...
Source: Bleichmar Fonti & Auld Llp
|
Feb 21, 2025 @ 10:32 PM
Lowey Dannenberg Notifies TransMedics Group, Inc. ...
Source: N/A
|
Feb 21, 2025 @ 1:14 AM
TMDX Investor Alert: A Securities Fraud Class Acti...
Source: Kessler Topaz Meltzer & Check, Llp
|
Feb 20, 2025 @ 10:56 PM
ROSEN, SKILLED INVESTOR COUNSEL, Encourages TransM...
Source: Rosen Law Firm
|
Feb 19, 2025 @ 6:55 PM
TRANSMEDICS GROUP, INC. (NASDAQ: TMDX) INVESTOR AL...
Source: Bernstein Liebhard Llp
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$.98
|
$.13
|
$.37
|
|
Diluted EPS
|
$.93
|
$.12
|
$.35
|
|
Revenue
|
$ 401.09M
|
$ 108.76M
|
$ 114.31M
|
|
Gross Profit
|
$ 237.99M
|
$ 60.85M
|
$ 69.26M
|
|
Net Income / Loss
|
$ 32.64M
|
$ 4.22M
|
$ 12.19M
|
|
Operating Income / Loss
|
$ 31.46M
|
$ 3.92M
|
$ 12.51M
|
|
Cost of Revenue
|
$ 163.1M
|
$ 47.92M
|
$ 45.04M
|
|
Net Cash Flow
|
$ -97.02M
|
$ -32.66M
|
$ 12.53M
|
|
PE Ratio
|
77.10
|
|
|
|
